Biomea Fusion, Inc.(BMEA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BMEA Biomea Fusion, Inc.

Closed Good Friday 04-17 16:00:00 EDT

1.69

+0.10

+6.29%

盘后1.69

-0.01-0.59%

18:23 EDT

High1.78	Low1.60	Vol868.40K
Open1.61	D1 Closing1.59	Amplitude11.63%
Mkt Cap63.50M	Tradable Cap49.68M	Total Shares37.57M
T/O1.45M	T/O Rate2.95%	Tradable Shares29.40M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"BMEA","market":"US","secType":"STK","nameCN":"Biomea Fusion, Inc.","latestPrice":1.69,"timestamp":1744920000000,"preClose":1.59,"halted":0,"volume":868399,"hourTrading":{"tag":"盘后","latestPrice":1.69,"preClose":1.7,"latestTime":"18:23 EDT","volume":1710,"amount":2892.856,"timestamp":1744928614359},"delay":0,"floatShares":29397595,"shares":37572250,"eps":-3.833912,"marketStatus":"Closed Good Friday","change":0.1,"latestTime":"04-17 16:00:00 EDT","open":1.61,"high":1.7799,"low":1.595,"amount":1448611.5420595,"amplitude":0.116289,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.833912,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"listingDate":1618545600000,"exchange":"NASDAQ","adjPreClose":1.59,"preHourTrading":{"tag":"盘前","latestPrice":1.64,"preClose":1.59,"latestTime":"09:24 EDT","volume":21365,"amount":35043.5374515,"timestamp":1744896249506},"postHourTrading":{"tag":"盘后","latestPrice":1.69,"preClose":1.7,"latestTime":"18:23 EDT","volume":1710,"amount":2892.856,"timestamp":1744928614359},"volumeRatio":1.3502403820241589,"impliedVol":0.7772,"impliedVolPercentile":0.1992},"requestUrl":"/m/hq/s/BMEA","defaultTab":"news","newsList":[{"id":"2524492984","title":"Biomea Fusion Is Maintained at Equal-Weight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2524492984","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524492984?lang=en_us&edition=full_marsco","pubTime":"2025-04-02 22:26","pubTimestamp":1743603960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BMEA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 02, 2025 10:26 ET (14:26 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BMEA","BK4585","BK4539"],"gpt_icon":0},{"id":"2524745643","title":"Barclays Sticks to Their Hold Rating for Biomea Fusion (BMEA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524745643","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524745643?lang=en_us&edition=full_marsco","pubTime":"2025-04-02 16:58","pubTimestamp":1743584288,"startTime":"0","endTime":"0","summary":"Barclays analyst Peter Lawson maintained a Hold rating on Biomea Fusion (BMEA – Research Report) today and set a price target of $3.00. The company...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-their-hold-rating-for-biomea-fusion-bmea?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-their-hold-rating-for-biomea-fusion-bmea?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMEA"],"gpt_icon":0},{"id":"2524129865","title":"BRIEF-Biomea Fusion, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524129865","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524129865?lang=en_us&edition=full_marsco","pubTime":"2025-04-02 04:07","pubTimestamp":1743538065,"startTime":"0","endTime":"0","summary":"BRIEF-Biomea Fusion, Inc. Reports Inducement Grants UnderNasdaq Listing Rule 5635(C)(4)April 1 (Reuters) - Biomea Fusion Inc BMEA.O:BIOMEA FUSION, INC. REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING R","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nTUA32BXDN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4585","BK4139","BMEA"],"gpt_icon":0},{"id":"2524126297","title":"Biomea Fusion, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524126297","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524126297?lang=en_us&edition=full_marsco","pubTime":"2025-04-02 04:01","pubTimestamp":1743537660,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nTUA32BXDN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BMEA","BK4139","BK4585","BK4539"],"gpt_icon":0},{"id":"2524126068","title":"Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524126068","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524126068?lang=en_us&edition=full_marsco","pubTime":"2025-04-02 04:01","pubTimestamp":1743537660,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif., April  01, 2025  (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or the “Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/01/3053774/0/en/Biomea-Fusion-Inc-Reports-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","USAW.SI","NDAQ","TQQQ","MNQmain","NQmain","BK4585","BK4112","USJW.SI","QID","BMEA",".IXIC","LU2210149790.SGD","QLD","BK4588","TSYW.SI","PSQ","NVIW.SI","LU2095319765.USD","LU2210150020.SGD","SQQQ","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BKPKM429.USD"],"gpt_icon":1},{"id":"2524114160","title":"Biomea Fusion Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2524114160","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524114160?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 21:31","pubTimestamp":1743514274,"startTime":"0","endTime":"0","summary":"Biomea Fusion Inc reports results for the quarter ended December 31 - Earnings SummaryBiomea Fusion Inc BMEA.OQ reported a quarterly adjusted loss of 81 cents per share for the quarter ended December ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nL5N3QF10E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMEA"],"gpt_icon":0},{"id":"2524997194","title":"Scotiabank Keeps Their Buy Rating on Biomea Fusion (BMEA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524997194","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524997194?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 18:55","pubTimestamp":1743504958,"startTime":"0","endTime":"0","summary":"In a report released today, George Farmer from Scotiabank maintained a Buy rating on Biomea Fusion (BMEA – Research Report), with a price target of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/scotiabank-keeps-their-buy-rating-on-biomea-fusion-bmea-7?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/scotiabank-keeps-their-buy-rating-on-biomea-fusion-bmea-7?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMEA"],"gpt_icon":0},{"id":"2524061749","title":"BRIEF-Biomea Fusion Q4 Basic EPS USD -0.81","url":"https://stock-news.laohu8.com/highlight/detail?id=2524061749","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524061749?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 06:41","pubTimestamp":1743460866,"startTime":"0","endTime":"0","summary":"BRIEF-Biomea Fusion Q4 Basic EPS USD -0.81March 31 (Reuters) - Biomea Fusion Inc BMEA.O:BIOMEA FUSION Q4 BASIC EPS USD -0.81BIOMEA FUSION Q4 NET INCOME USD -29.302 MILLIONBIOMEA FUSION Q4 OPERATING IN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nPLX05B25A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMEA"],"gpt_icon":0},{"id":"2524977793","title":"Biomea Fusion reports Q4 EPS (81c), consensus (93c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2524977793","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524977793?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 04:30","pubTimestamp":1743453012,"startTime":"0","endTime":"0","summary":"“2024 was a transformative year for Biomea, marked by the advancement of icovamenib into late-stage development and compelling clinical data that r...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biomea-fusion-reports-q4-eps-81c-consensus-93c?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biomea-fusion-reports-q4-eps-81c-consensus-93c?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMEA"],"gpt_icon":0},{"id":"2524974426","title":"Biomea Fusion Q4 Operating Income USD -30.074 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2524974426","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524974426?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 04:10","pubTimestamp":1743451800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nPLX05B25A:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BMEA","BK4585","BK4139"],"gpt_icon":0},{"id":"2524744419","title":"Biomea Fusion Q4 Net Income USD -29.302 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2524744419","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524744419?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 04:10","pubTimestamp":1743451800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nPLX05B25A:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BMEA","BK4539","BK4585","BK4139"],"gpt_icon":0},{"id":"2524974473","title":"Press Release: Biomea Fusion Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2524974473","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524974473?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 04:10","pubTimestamp":1743451800,"startTime":"0","endTime":"0","summary":"-- Mick Hitchcock, Ph.D., appointed Interim Chief Executive Officer. -- Biomea preparing icovamenib for late-stage clinical development. -- COVALENT-112  open label data anticipated in second half 2025. \"2024 was a transformative year for Biomea, marked by the advancement of icovamenib into late-stage development and compelling clinical data that reinforced our confidence in its potential to reshape diabetes treatment, particularly for patients with severe insulin deficiency,\" said Mick Hitchcock, Ph.D., Interim Chief Executive Officer and Board Member of Biomea Fusion. \"As we move into this next phase, the Board made a strategic decision to align leadership with the company's evolution, and I'm honored to step in and contribute decades of experience in late-stage development, regulatory strategy, and commercialization to help guide Biomea forward. This transition reflects the continued confidence in our menin inhibitor program and the strength of our covalent small molecule platform. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4604","BK4588","BK4099","03160","BK4555","TM","BMEA"],"gpt_icon":0},{"id":"2523192193","title":"After Plunging -20.42% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2523192193","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523192193?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 21:35","pubTimestamp":1743428105,"startTime":"0","endTime":"0","summary":"Biomea Fusion, Inc.  has been on a downward spiral lately with significant selling pressure. After declining 20.4% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.We use Relative Strength Index , one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price movements.RSI oscillates between zero and 100. Usually, a stock is considered oversold when its RSI reading falls below 30.Technically, every stock oscillates between being overbought and oversold irrespective of the quality of their fundamentals. And the beauty of RSI is that it helps you quickly and easily check if a stock's price is reaching a point of reversal.This article originally published on Zacks Investment Research .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/plunging-20-42-4-weeks-133505009.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4150","BK4139","BMEA","BK4539","RSI"],"gpt_icon":0},{"id":"2523941530","title":"Biomea Fusion Price Target Maintained With a $40.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2523941530","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523941530?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 20:52","pubTimestamp":1743425520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BMEA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 31, 2025 08:52 ET (12:52 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMEA"],"gpt_icon":0},{"id":"2522571356","title":"Biomea Fusion Inc  expected to post a loss of 92 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2522571356","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522571356?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 20:52","pubTimestamp":1743166327,"startTime":"0","endTime":"0","summary":"Biomea Fusion Inc  expected to post a loss of92cents a share - Earnings Preview Biomea Fusion Inc BMEA.OQ BMEA.O is expected to show no change in quarterly revenue when it reports  results on April 1 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nL5N3QB0ZK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMEA"],"gpt_icon":0},{"id":"2522532478","title":"Biomea Fusion Appoints Interim CEO Amid Leadership Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2522532478","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522532478?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 04:55","pubTimestamp":1743108916,"startTime":"0","endTime":"0","summary":"Biomea Fusion ( ($BMEA) ) just unveiled an announcement. On March 25, 2025, Biomea Fusion announced leadership changes with Dr. Michael J.M. Hitchc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biomea-fusion-appoints-interim-ceo-amid-leadership-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biomea-fusion-appoints-interim-ceo-amid-leadership-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BMEA","BK4585","BK4139"],"gpt_icon":0},{"id":"2522283777","title":"Biomea Fusion Names Hitchcock as Interim CEO, Succeeding Butler","url":"https://stock-news.laohu8.com/highlight/detail?id=2522283777","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522283777?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 07:35","pubTimestamp":1742945700,"startTime":"0","endTime":"0","summary":"Biomea Fusion appointed one of its board members, Mick Hitchcock, to succeed Thomas Butler as its interim chief executive.The change will help to ensure the company realizes its full potential developing a novel therapy for diabetes, it said Tuesday.Hitchcock has served on the Redwood City, Calif., company's board since March 2021. His career in the pharmaceutical industry began in 1980. He has since held a variety of roles, including leadership positions, at companies including Bristol-Myers Squibb and Gilead Sciences.As CEO, Hitchcock said he plans to continue the work he has done on Biomea's board. In addition to advancing late stage development efforts and preparing for regulatory engagement regarding Biomea's icovamenib, the company will work to develop its product candidates for the treatment of diabetes.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4539","BK4139","BMEA"],"gpt_icon":0},{"id":"2522083253","title":"BRIEF-Biomea Fusion Says Mick Hitchcock Named Interim CEO Replacing Thomas Butler","url":"https://stock-news.laohu8.com/highlight/detail?id=2522083253","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522083253?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 07:01","pubTimestamp":1742943682,"startTime":"0","endTime":"0","summary":"BRIEF-Biomea Fusion Says Mick Hitchcock Named Interim CEO Replacing Thomas ButlerMarch 25 (Reuters) - Biomea Fusion Inc BMEA.O:BIOMEA FUSION ANNOUNCES LEADERSHIP TRANSITIONBIOMEA FUSION INC - MICK HIT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nTUA9MHM3S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","BMEA","BK4585"],"gpt_icon":0},{"id":"2522983232","title":"Biomea Fusion Announces Leadership Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2522983232","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522983232?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 07:00","pubTimestamp":1742943602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nTUA9MHM3S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","BK4585","BMEA"],"gpt_icon":0},{"id":"2522320832","title":"Biomea Fusion Inc - Mick Hitchcock to Succeed Thomas Butler as Interim CEO Effective Immediately","url":"https://stock-news.laohu8.com/highlight/detail?id=2522320832","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522320832?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 07:00","pubTimestamp":1742943602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nTUA9MHM3S:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4585","BMEA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biomeafusion.com","stockEarnings":[{"period":"1week","weight":-0.0231},{"period":"1month","weight":-0.332},{"period":"3month","weight":-0.5748},{"period":"6month","weight":-0.8549},{"period":"1year","weight":-0.853},{"period":"ytd","weight":-0.5644}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. Biomea Fusion, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.103218},{"month":2,"riseRate":0.25,"avgChangeRate":-0.024175},{"month":3,"riseRate":0.25,"avgChangeRate":0.175552},{"month":4,"riseRate":0,"avgChangeRate":-0.216298},{"month":5,"riseRate":0.75,"avgChangeRate":0.245778},{"month":6,"riseRate":0.25,"avgChangeRate":0.039512},{"month":7,"riseRate":0.5,"avgChangeRate":-0.004694},{"month":8,"riseRate":0.75,"avgChangeRate":0.054176},{"month":9,"riseRate":0.25,"avgChangeRate":-0.024488},{"month":10,"riseRate":0.25,"avgChangeRate":-0.076889},{"month":11,"riseRate":0.5,"avgChangeRate":0.006178},{"month":12,"riseRate":0.25,"avgChangeRate":-0.177722}],"exchange":"NASDAQ","name":"Biomea Fusion, Inc.","nameEN":"Biomea Fusion, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biomea Fusion, Inc.(BMEA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Biomea Fusion, Inc.(BMEA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Biomea Fusion, Inc.,BMEA,Biomea Fusion, Inc.股票,Biomea Fusion, Inc.股票老虎,Biomea Fusion, Inc.股票老虎国际,Biomea Fusion, Inc.行情,Biomea Fusion, Inc.股票行情,Biomea Fusion, Inc.股价,Biomea Fusion, Inc.股市,Biomea Fusion, Inc.股票价格,Biomea Fusion, Inc.股票交易,Biomea Fusion, Inc.股票购买,Biomea Fusion, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biomea Fusion, Inc.(BMEA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Biomea Fusion, Inc.(BMEA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}